Access to huge patient datasets and improvements in analytical methods is enabling the teasing apart of complex diseases into distinct patient subgroups that have different root causes and influences. This offers huge promise for innovation in drug discovery and the delivery of personalised care to patients.
To view the article in full, please see https://app.box.com/s/fs9xp8b49l5ycm7yxf6cmfbu3idlk005